Literature DB >> 4161902

A serological study of primary thymic neoplasms.

B I Hoffbrand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4161902      PMCID: PMC1019035          DOI: 10.1136/thx.21.3.263

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  11 in total

1.  CLINICAL DISORDERS ASSOCIATED WITH THYMIC TUMORS.

Authors:  M RUBIN; B STRAUS; L ALLEN
Journal:  Arch Intern Med       Date:  1964-09

2.  MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS.

Authors:  H VAN DER GELD; T E FELTKAMP; J VAN LOGHEM; H J OOSTERHUIS; A BIEMOND
Journal:  Lancet       Date:  1963-08-24       Impact factor: 79.321

3.  HYPERGLOBULINAEMIC PURPURA DUE TO A THYMIC TUMOUR.

Authors:  C A BIRCH; K B COOKE; C E DREW; D R LONDON; D H MACKENZIE; M D MILNE
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

4.  IMMUNOLOGICAL DISTURBANCES IN MYASTHENIA GRAVIS WITH A REPORT OF HASHIMOTO'S DISEASE DEVELOPING AFTER THYMECTOMY.

Authors:  J A SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-12       Impact factor: 10.154

5.  THYMECTOMY FOR MYASTHENIA GRAVIS.

Authors:  R A HENSON; G M STERN; V C THOMPSON
Journal:  Brain       Date:  1965-03       Impact factor: 13.501

6.  Thymic tumour and erythroblastic aplasia. Report of three cases and a review of the syndrome.

Authors:  C W HAVARD; R B SCOTT
Journal:  Br J Haematol       Date:  1960-04       Impact factor: 6.998

7.  Hypogammaglobulinaemia in chronic lymphatic leukaemia.

Authors:  G H FAIRLEY; R B SCOTT
Journal:  Br Med J       Date:  1961-10-07

8.  Studies on sera from cases of myasthenia gravis, using the fluorescent antibody technique.

Authors:  T E Feltkamp; H van der Geld; H J Oosterhuis
Journal:  Vox Sang       Date:  1963 May-Jun       Impact factor: 2.144

9.  ROLE OF THE THYMUS IN IMMUNITY.

Authors:  J F MILLER
Journal:  Br Med J       Date:  1963-08-24

10.  The histology of tumours of the thymus.

Authors:  A D THOMSON; A C THACKRAY
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.